Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 27:11:81.
doi: 10.4103/abr.abr_103_21. eCollection 2022.

A Retrospective Cytogenetic Abnormality in Pediatric Acute Lymphoblastic Leukemia: Report of 11 Years

Kazem Ghaffari  1 , Athena Kouhfar  2 , Ali Ghasemi  3 , Milad Gholami  4 , Ali Arjmand  5 , Vahid Falahati  2
Affiliations

A Retrospective Cytogenetic Abnormality in Pediatric Acute Lymphoblastic Leukemia: Report of 11 Years

Kazem Ghaffari et al. Adv Biomed Res. .

Abstract

Background: Acute lymphoid leukemia (ALL) is the largest subset of hematologic malignancies, accounting for approximately 70%-80% of childhood leukemia, and is most common at age 4 years. The aim of this study was to define the frequency of chromosomal abnormalities in pediatric ALL.

Materials and methods: In this 11-year retrospective study, we investigated 99 patients which referred to our department due to ALL from 2010 to 2020. The age group of the patients ranged from 6 months to 14 years with a mean of 6.71 ± 4.09 years. Clinical and diagnostic findings were extracted from patients' medical records.

Results: We showed cytogenetic abnormalities of 99 pediatric ALL patients, including 78 pre-B-ALL, 9 common B-ALL, and 12 T-ALL cases. The 5-year overall survival rate (OSR) and event-free survival (EFS) of all cytogenetic abnormalities (n = 99) were 48% and 43%, respectively. There was a significant relationship between the two cytogenetic abnormalities, hypodiploidy and t(9;22), with death (P < 0.05). On comparing the subjects with normal cytogenetics to the other cytogenetic abnormalities, EFS was significantly low for hypodiploidy (P = 0.0163, hazard ratio = 0.5308) and t(9;22) (P = 0.0131, hazard ratio = 0.4908), while other cytogenetic abnormalities did not have a statistically significant difference in EFS.

Conclusions: Our results emphasized the importance of the cytogenetic findings in evaluating the survival outcomes, which allows identifying a variety of OSR and EFS, because some of the cytogenetic abnormalities may interfere with the death and prognosis.

Keywords: Acute lymphoblastic leukemia; cytogenetic abnormalities; karyotype; overall survival.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Estimated overall survival rate of all enrolled patients based on cytogenetic abnormality. Kaplan–Meier estimate for OSR of (a) the six cytogenetic abnormalities, (b) normal cytogenetic versus t(1;19), (c) normal cytogenetic versus t(12;21), (d) normal cytogenetic versus t(9;22), (e) normal cytogenetic versus hyperdiploidy, (f) normal cytogenetic versus hypodiploidy, and (g) normal cytogenetic versus miscellaneous
Figure 2
Figure 2
Estimated event-free survival of all enrolled patients based on cytogenetic abnormality. Kaplan–Meier estimate for event-free survival of (a) the six cytogenetic abnormalities, (b) normal cytogenetic versus t(12;21), (c) normal cytogenetic versus t(1;19), (d) normal cytogenetic versus t(9;22), (e) normal cytogenetic versus hyperdiploidy, (f) normal cytogenetic versus hypodiploidy, and (g) normal cytogenetic versus miscellaneous
See this image and copyright information in PMC

References

    1. Parkin DM, Stiller CA, Draper GJ, Bieber CA. International incidence of childhood cancer. Int J Cancer. 1988;42:511–20. - PubMed
    1. Belson M, Kingsley B, Holmes A. Risk factors for acute leukemia in children: A review. Environ Health Perspect. 2007;115:138–45. - PMC - PubMed
    1. Dastgiri S, Fozounkhah S, Shokrgozar S, Taghavinia M, Asvadi Kermani A. Incidence of leukemia in the northwest of Iran. Health Promot Perspect. 2011;1:50–3. - PMC - PubMed
    1. Kulkarni KP, Arora RS, Marwaha RK. Survival outcome of childhood acute lymphoblastic leukemia in India: A resource-limited perspective of more than 40 years. J Pediatr Hematol Oncol. 2011;33:475–9. - PubMed
    1. Ghasemi A, Rostami S, Chahardouli B, Alizad Ghandforosh N, Ghotaslou A, Nadali F. Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia. Int J Hematol Oncol Stem Cell Res. 2015;9:15–21. - PMC - PubMed